Geron Corporation (NASDAQ:GERN) current P/S is an unimpressive 61.93. The overall Major Pharmaceuticals group has an average P/S ratio of 49.46, which is significantly worse than the sector’s 7.92.

GERN traded at an unexpectedly low level on 07/22/2019 when the stock experienced a -5.69% loss to a closing price of $1.16. The company saw 1542153 shares trade hands over the course of the day. Given that its average daily volume over the 5 sessions has been 1699140 shares a day, this signifies a pretty significant change over the norm.

Geron Corporation (GERN) Analyst Gushes

Analysts are speculating a 287.93% move, based on the high target price ($4.5) for the shares that is set to reach in the next 12 months. The analysts, on average, are forecasting a $3.83 price target, but the stock is already up 21.5% from its recent lows. However, the stock is trading at -83.4% versus recent highs ($6.99). Analysts believe that we could see stock price minimum in the $3 range (lowest target price), allowing for another 158.62% jump from its current position. Leading up to this report, we have seen a -24.18% fall in the stock price over the last 30 days and a -39.58% decline over the past 3 months. Overall, the share price is up 16% so far this year. Additionally, the stock had a day price range of $1.155 to $1.23.

Geron Corporation (GERN) Price Potential

Heading into the stock price potential, Geron Corporation needs to grow just 244.83% to cross its median price target of $4. In order to determine directional movement, the 50-day and 200-day moving averages for Geron Corporation (NASDAQ:GERN) are $1.4071 and $1.4958. Given that liquidity is king in the short-term, GERN is a stock with 189.51 million shares outstanding that normally trades 24.26% of its float. The stock price recently experienced a 5-day loss of -5.69% with 0.09 average true range (ATR). GERN has a beta of 2.57 and RSI is 29.33.

Investors also need to beware of the DURECT Corporation (NASDAQ:DRRX) valuations. The stock trades on a P/S of 7.24, which suggests that the shares are attractive compared with peers. The broad Major Pharmaceuticals industry has an average P/S ratio of 42.23, which is significantly worse than the sector’s 7.97.

DURECT Corporation (DRRX)’s Lead Over its Technicals

DURECT Corporation by far traveled 111.09% versus a 1-year low price of $0.46. The share price was last seen 33.64% higher, reaching at $0.97 on Jul. 22, 2019. At recent session, the prices were hovering between $0.8001 and $1.05. This company shares are 160.82% off its target price of $2.53 and the current market capitalization stands at $172.16M. The recent change has given its price a 53.6% lead over SMA 50 and -41.5% deficit over its 52-week high. The stock witnessed 66.38% gains, 71.68% gains and 67.41% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found DRRX’s volatility during a week at 10.59% and during a month it has been found around 9.33%.

DURECT Corporation (NASDAQ:DRRX) Intraday Metrics

DURECT Corporation (DRRX) exchanged hands at an unexpectedly high level of 13130589 shares over the course of the day. Noting its average daily volume at 2924700 shares each day over the month, this signifies a pretty significant change over the norm.

DURECT Corporation Target Levels

The market experts are predicting a 467.01% rally, based on the high target price of $5.5 for DURECT Corporation shares that is likely to be hit in the 52 weeks. Analysts anticipate that traders could see stock price minimum in the $1.1 range (lowest target price). If faced, it would be a 13.4% jump from its current position. Overall, the share price is up 100.99% year to date [T2].